Skip to main content
. 2018 Jul 16;51(2):556–567. doi: 10.4143/crt.2018.221

Table 1.

Baseline characteristics of prostate cancer patients (n=209)

Variable Total (n=209) Open (n=41) Laparoscopic (n=63) Robot (n=105) p-value
Age (yr) 66.6±6.6 67.6±6.1 67.5±6.2 65.7±6.9 0.124
Height (cm) 166.7±5.6 166.5±6.3 167.0±5.5 166.9±5.4 0.881
Weight (kg) 66.8±8.4 66.9±9.1 66.5±8.6 67.0±8.0 0.931
Comorbidity, any 118±56.5 26±63.4 35±55.6 57±54.3 0.598
Education level
 Less than high school 112 (53.9) 27 (65.9) 37 (58.7) 48 (46.2) 0.065
 High school and above 96 (46.1) 14 (34.1) 26 (41.3) 56 (53.8)
Marital status
 Married 187 (89.5) 39 (95.1) 53 (84.1) 95 (90.5) 0.181
 Unmarried 22 (10.5) 2 (4.9) 10 (15.9) 10 (9.5)
Smoking
 Current 22 (10.6) 3 (7.3) 7 (11.1) 12 (11.5) 0.386
 Past 120 (57.7) 24 (58.5) 31 (49.2) 65 (62.5)
 None 66 (31.7) 14 (34.2) 25 (39.7) 27 (26.0)
Drinking
 Current 84 (40.2) 16 (39.0) 20 (31.8) 48 (45.7) 0.349
 Past 69 (33.0) 14 (34.2) 21 (33.3) 34 (32.4)
 None 56 (26.8) 11 (26.8) 22 (34.9) 23 (21.9)
Pathologic T category
 2 153 (73.2) 29 (70.7) 40 (63.5) 84 (80.0) 0.060
 3 56 (26.8) 12 (29.3) 23 (36.5) 21 (20.0)
Pathologic N category
 0 100 (47.9) 27 (65.9) 29 (46.03) 44 (41.9) 0.053
 1 3 (1.4) 0 0 3 (2.9)
 x 106 (50.7) 14 (34.1) 34 (53.97) 58 (55.2)
Pathologic Gleason score
 6 41 (19.6) 6 (14.6) 15 (23.8) 20 (19.1) 0.795
 7 130 (62.2) 26 (63.4) 37 (58.7) 67 (63.8)
 ≥ 8 38 (18.2) 9 (22.0) 11 (17.5) 18 (17.1)
PSA (ng/mL) 10.4±11.9 8.6±7.1 10.9±9.5 10.7±14.5 0.578
Karnofsky performance status
 100 159 (76.4) 21 (52.5) 63 (100) 75 (71.4) < 0.001
 90 47 (22.6) 17 (42.5) 0 30 (28.6)
 80 2 (1.0) 2 (5.0) 0 0

Values are presented as mean±standard deviation or number (%). Numbers may not sum to total number due to missing responses. p-values were calculated by chi-square test or Fisher exact test. PSA, prostate-specific antigen.